Cargando…
Emerging Nanotechnology for Treatment of Alzheimer’s and Parkinson’s Disease
The prevalence of the two most common neurodegenerative diseases, Parkinson’s disease (PD) and Alzheimer’s Disease (AD), are expected to rise alongside the progressive aging of society. Both PD and AD are classified as proteinopathies with misfolded proteins α-synuclein, amyloid-β, and tau. Emerging...
Autores principales: | Li, Amanda, Tyson, Joel, Patel, Shivni, Patel, Meer, Katakam, Sruthi, Mao, Xiaobo, He, Weiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185219/ https://www.ncbi.nlm.nih.gov/pubmed/34113606 http://dx.doi.org/10.3389/fbioe.2021.672594 |
Ejemplares similares
-
The application of nanotechnology in treatment of Alzheimer’s disease
por: Cao, Yanyan, et al.
Publicado: (2022) -
The emerging role of cancer nanotechnology in the panorama of sarcoma
por: Mercatali, Laura, et al.
Publicado: (2022) -
The Emerging Applications of Nanotechnology in Neuroimaging: A Comprehensive Review
por: Faiz, Khunza, et al.
Publicado: (2022) -
Emerging applications of nanotechnology in context to immunology: A comprehensive review
por: Mobeen, Hifsa, et al.
Publicado: (2022) -
The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders
por: Ngowi, Ebenezeri Erasto, et al.
Publicado: (2021)